ARVINAS, INC. Contract with Customer, Liability, Noncurrent
ARVINAS, INC. (ARVN) had Contract with Customer, Liability, Noncurrent of $0 as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-08-04
- 2026-06-30: Contract with Customer, Liability, Noncurrent $0.00.
- 2026-03-31: Contract with Customer, Liability, Noncurrent $138.20M.
- 2025-12-31: Contract with Customer, Liability, Noncurrent $134.30M.
- 2025-09-30: Contract with Customer, Liability, Noncurrent $127.40M.
| Period end | Contract with Customer, Liability, Noncurrent | Contract with Customer, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $138.20M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $134.30M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $127.40M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $134.10M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $118.40M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $292.00M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $304.50M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $331.30M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $361.00M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $386.20M 10-K · filed 2025-02-11 | |
| 2023-09-30 | $281.90M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $310.50M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $378.90M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $405.10M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $464.60M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $493.60M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $521.90M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $534.30M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $600.43M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $14.86M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $20.40M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $22.90M 10-K · filed 2022-02-28 | $22.94M 10-K · filed 2021-03-01 |
| 2020-09-30 | $23.95M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $27.49M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $33.73M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $38.43M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $41.77M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $30.70M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $34.09M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $37.48M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $40.71M 10-Q · filed 2018-11-14 | |
| 2017-12-31 | $48.55M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |